Literature DB >> 8882027

Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis.

J K Walsh1, M J Muehlbach, S A Lauter, N A Hilliker, P K Schweitzer.   

Abstract

OBJECTIVE: To evaluate the effects of triazolam upon insomnia and daytime sleepiness in patients with rheumatoid arthritis (RA).
METHODS: Triazolam or placebo was administered during two 7 night periods to 15 patients with RA in a double blind crossover study. Polysomnographic recordings were conducted on the last 2 nights of each condition, and multiple sleep latency tests and mood and arthritis assessments were performed during the intervening day in each condition.
RESULTS: In the triazolam condition, total sleep time was increased, daytime sleepiness was reduced, and morning stiffness was improved compared to placebo. Objective measures of sleep fragmentation were unchanged. Clinical arthritis assessments were similar during both conditions.
CONCLUSION: Short term hypnotic therapy improves sleep in patients with RA and appears to improve morning stiffness and daytime sleepiness.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882027

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons.

Authors:  Jared Minkel; Andrew D Krystal
Journal:  Sleep Med Clin       Date:  2013-09-01

2.  Sleep quality and correlates of poor sleep in patients with rheumatoid arthritis.

Authors:  K Løppenthin; B A Esbensen; P Jennum; M Østergaard; A Tolver; T Thomsen; J Midtgaard
Journal:  Clin Rheumatol       Date:  2015-01-27       Impact factor: 2.980

3.  Sleep quality and functional disability in patients with rheumatoid arthritis.

Authors:  Faith S Luyster; Eileen R Chasens; Mary Chester M Wasko; Jacqueline Dunbar-Jacob
Journal:  J Clin Sleep Med       Date:  2011-02-15       Impact factor: 4.062

4.  Effectiveness of Benzodiazepine Receptor Agonists in the Treatment of Insomnia: An Examination of Response and Remission Rates.

Authors:  Vivek Pillai; Thomas Roth; Timothy Roehrs; Kenneth Moss; Edward L Peterson; Christopher L Drake
Journal:  Sleep       Date:  2017-02-01       Impact factor: 5.849

5.  Sleep and pain in humans with fibromyalgia and comorbid insomnia: double-blind, crossover study of suvorexant 20 mg versus placebo.

Authors:  Timothy Roehrs; Dana Withrow; Gail Koshorek; Jelena Verkler; Luisa Bazan; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2020-01-14       Impact factor: 4.062

6.  Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis.

Authors:  Michael R Irwin; Richard Olmstead; Carmen Carrillo; Nina Sadeghi; John D Fitzgerald; Veena K Ranganath; Perry M Nicassio
Journal:  Sleep       Date:  2012-04-01       Impact factor: 5.849

7.  How representative are insomnia clinical trials?

Authors:  T Roehrs; J C Verster; G Koshorek; D Withrow; T Roth
Journal:  Sleep Med       Date:  2018-06-26       Impact factor: 3.492

8.  The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study.

Authors:  Thomas Roth; Janet M Price; David A Amato; Robert P Rubens; James M Roach; Thomas J Schnitzer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 9.  Does effective management of sleep disorders improve pain symptoms?

Authors:  Timothy A Roehrs
Journal:  Drugs       Date:  2009       Impact factor: 9.546

10.  A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.

Authors:  Harold W Goforth; Xavier A Preud'homme; Andrew D Krystal
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.